SOLACI-CACI 2021 | Complex Pulmonary Hypertension and Aortic Endovascular Aneurysm Session

✔️ Watch again the Session on “Complex Pulmonary Hypertension and Aortic Endovascular Aneurysm” in the SOLACI-CACI 2021 Congress.

👨‍🏫 Program:

SESSION I: Chronic Thromboembolic Pulmonary Hypertension

  • 02:48 – Definition, epidemiology, diagnostic algorithm and pharmacological treatment. – Pedro Trujillo
  • 16:27 – Invasive Endovascular Strategies in Chronic PTE: Pulmonary Angioplasty – Fabio Solano
  • 30:13 – Surgical Thromboendarterectomy. Current Indications and Outcomes – Mariano Camporrotondo

👉🏻 Panelists: Damonte, Marcelo – Fernández, Juan – Gottschald, Marcelo – Leite, Marta – Nahin, Marcelo

SESSION II: Aortic Aneurysms

  • 51:50 – Abdominal Aortic Artery: Different Necks, Different Devices: Options Overview – Juan Varela
  • 01:03:37 – Thoracic Aorta. The Subclavian Artery. How Can We Obtain a Correct Proximal Neck? Complete and Incomplete Debranching – Chang Shu
  • 01:15:59 – Type B Dissection in Sub-Acute Stage: When and How to Intervene – Douglas Cavaye

👉🏻 Panelists: Furuya, Luis – Mendaro, Esteban – Michel, David – Razuk, Álvaro
👉🏻 Chairpersons: José Álvarez, Mariano Ferreira & Marco Martínez Ríos
👉🏻 Digital Moderator: Juan Arellano


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

A New Asymptomatic Carotid Stenosis Paradigm? CREST-2 Trial Unified Results

Severe asymptomatic carotid stenosis continues to be controversial seeing the optimization of intensive medical therapy (IMT) and the availability lower periprocedural risk revascularization techniques....

Impact of Baseline Systolic Blood Pressure on Blood Pressure Changes Following Renal Denervation

Renal denervation (RDN) is a guideline-recommended therapy to reduce blood pressure in patients with uncontrolled hypertension, although uncertainties remain regarding which factors best predict...

Hypertriglyceridemia as Key Factor to Abdominal Aortic Aneurysm Development and Rupture: Genetic and Experimental Evidence

Abdominal aortic aneurysm (AAA) is a deadly vascular disease with no effective drug treatment, and risk of rupture reaching up to 80%. Even though...

Atrial Fibrillation and Chronic Kidney Disease: Outcomes of Different Stroke Prevention Strategies

Atrial fibrillation (AF) affects approximately 1 in every 4 patients with end-stage renal disease (ESRD). This population carries a high burden of comorbidities and...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Transapical TMVR in High Risk Patients: Intrepid 5-Year Outcomes

Moderate to severe mitral valve regurgitation (MR) continues is still a high prevalence condition with bad prognosis, particularly among the elderly with left ventricular...

EMERALD II: Non-Invasive Coronary Anatomy and Physiology (CCTA) in ACS Prediction

Despite steady progress in secondary prevention and medical treatment optimization (OMT), acute coronary syndrome (ACS) remains one of the leading causes of cardiovascular morbimortality....

Impact of Balloon Post-Dilation on the Long-Term Durability of Bioprostheses after TAVR

Balloon post-dilation (BPD) during transcatheter aortic valve replacement (TAVR) allows for the optimization of prosthesis expansion and the reduction of residual paravalvular aortic regurgitation....